TRAL Drug Patent Profile
✉ Email this page to a colleague
When do Tral patents expire, and what generic alternatives are available?
Tral is a drug marketed by Abbvie and Am Regent and is included in two NDAs. There is one patent protecting this drug.
The generic ingredient in TRAL is cupric sulfate; manganese sulfate; selenious acid; zinc sulfate. One supplier is listed for this compound. Additional details are available on the cupric sulfate; manganese sulfate; selenious acid; zinc sulfate profile page.
DrugPatentWatch® Generic Entry Outlook for Tral
Indicators of Generic Entry
Summary for TRAL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Patent Applications: | 840 |
Drug Prices: | Drug price information for TRAL |
DailyMed Link: | TRAL at DailyMed |